Literature DB >> 4707796

Clonidine in the treatment of severe hypertension.

J Raftos, G E Bauer, R G Lewis, G S Stokes, A S Mitchell, A A Young, I Maclachlan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4707796

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  10 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1977

Review 3.  Antihypertensive medications and depression.

Authors:  M H Beers; L J Passman
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

4.  Drug interactions with antihypertensive drugs.

Authors:  J E Crook; A S Nies
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

5.  Antihypertensive drug therapy.

Authors:  F O Simpson
Journal:  Drugs       Date:  1973       Impact factor: 9.546

6.  Depression and chronic clonidine therapy.

Authors:  A Prasad; K Shotliff
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

7.  Pharmacokinetics and side-effects of clonidine.

Authors:  A Keränen; S Nykänen; J Taskinen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

8.  Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors:  T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

9.  Clonidine withdrawal. Mechanism and frequency of rebound hypertension.

Authors:  G G Geyskes; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

10.  Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects.

Authors:  S N Anavekar; B Jarrott; M Toscano; W J Louis
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.